Phathom Pharmaceuticals, Inc. (PHAT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Phathom Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.47x | -1.53x | -2.32x | -2.22x | -5.06x | -8.55x |
| P/B Ratio | -2.76x | -2.02x | -6.44x | -5.87x | 10.09x | 5.68x |
| P/S Ratio | 6.91x | 9.28x | 686.61x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 87.1% | 85.6% | 75.5% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -91.4% | -502.2% | -24532.6% | 0.0% | 0.0% | 0.0% |
| Net Margin | -126.3% | -605.1% | -29558.9% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -91.0% | -473.3% | -23321.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.73x | 4.20x | 10.25x | 6.12x | 9.86x | 5.25x |
| Quick Ratio | 1.69x | 4.16x | 10.22x | 6.12x | 9.86x | 5.25x |
| Leverage | ||||||
| Debt/Equity | -0.01x | -2.19x | -1.91x | -1.30x | 1.27x | 0.25x |
YoY = year-over-year change. Source: FMP..